Testing the gene expression difference among patients with high-risk and low-risk score revealed a total of 14 genes with significant differences between the two groups (Fig. 5A), such as SEZ6L [35], IGFBP1 [36], which are well-established to be implicated in lung cancer development. Here, SEZ6L is linked to lung cancer.